Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04528836 |
Title | First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Navire Pharma Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham | Birmingham | Alabama | 35249 | United States | Details | |
City of Hope | Duarte | California | 91010 | United States | Details | |
Scripps MD Anderson Cancer Center | La Jolla | California | 92037 | United States | Details | |
UC Irvine Health | Orange | California | 92868 | United States | Details | |
UCLA Hematology/Oncology - Santa Monica | Santa Monica | California | 90404 | United States | Details | |
Sarah Cannon Research Institute | Denver | Colorado | 80218 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77096 | United States | Details | |
Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details | |
NEXT Virginia | Fairfax | Virginia | 22031 | United States | Details | |
MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | United States | Details |